pioglitazone has been researched along with Muscle Contraction in 6 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
Excerpt | Relevance | Reference |
---|---|---|
"The present study investigates the effect of pioglitazone treatment on blood pressure, vascular reactivity and antioxidant enzymes in L-NAME induced hypertension in normal and STZ-diabetic rats." | 7.73 | Effect of pioglitazone on L-NAME induced hypertension in diabetic rats. ( Balaraman, R; Majithiya, JB; Parmar, AN; Trivedi, CJ, 2005) |
"The present study investigates the effect of pioglitazone treatment on blood pressure, vascular reactivity and antioxidant enzymes in L-NAME induced hypertension in normal and STZ-diabetic rats." | 3.73 | Effect of pioglitazone on L-NAME induced hypertension in diabetic rats. ( Balaraman, R; Majithiya, JB; Parmar, AN; Trivedi, CJ, 2005) |
" Phenylephrine, ACh, and SNP dose-response curves were impaired to different extents in arteries of SHROBs." | 1.37 | Reactivity of the aorta and mesenteric resistance arteries from the obese spontaneously hypertensive rat: effects of glitazones. ( Llorens, S; Mendizábal, Y; Nava, E, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greulich, S | 1 |
Chen, WJ | 1 |
Maxhera, B | 1 |
Rijzewijk, LJ | 1 |
van der Meer, RW | 1 |
Jonker, JT | 1 |
Mueller, H | 1 |
de Wiza, DH | 1 |
Floerke, RR | 1 |
Smiris, K | 1 |
Lamb, HJ | 1 |
de Roos, A | 1 |
Bax, JJ | 1 |
Romijn, JA | 1 |
Smit, JW | 1 |
Akhyari, P | 1 |
Lichtenberg, A | 1 |
Eckel, J | 1 |
Diamant, M | 1 |
Ouwens, DM | 1 |
Kunasegaran, T | 1 |
Mustafa, MR | 1 |
Murugan, DD | 1 |
Achike, FI | 1 |
Mendizábal, Y | 1 |
Llorens, S | 1 |
Nava, E | 1 |
Iida, KT | 1 |
Kawakami, Y | 1 |
Suzuki, M | 1 |
Shimano, H | 1 |
Toyoshima, H | 1 |
Sone, H | 1 |
Shimada, K | 1 |
Iwama, Y | 1 |
Watanabe, Y | 1 |
Mokuno, H | 1 |
Kamata, K | 1 |
Yamada, N | 1 |
Majithiya, JB | 1 |
Parmar, AN | 1 |
Trivedi, CJ | 1 |
Balaraman, R | 1 |
Peuler, JD | 1 |
Miller, JA | 1 |
Bourghli, M | 1 |
Zammam, HY | 1 |
Soltis, EE | 1 |
Sowers, JR | 1 |
6 other studies available for pioglitazone and Muscle Contraction
Article | Year |
---|---|
Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies.
Topics: Adipose Tissue; Aged; Animals; Case-Control Studies; Cytokines; Diabetes Mellitus, Type 2; Gene Expr | 2013 |
The bioflavonoid quercetin synergises with PPAR-γ agonist pioglitazone in reducing angiotensin-II contractile effect in fructose-streptozotocin induced diabetic rats.
Topics: Angiotensin II; Animals; Aorta; Diabetes Mellitus, Experimental; Fructose; Male; Muscle Contraction; | 2016 |
Reactivity of the aorta and mesenteric resistance arteries from the obese spontaneously hypertensive rat: effects of glitazones.
Topics: Animals; Aorta; Blood Pressure; Endothelium, Vascular; Hypoglycemic Agents; In Vitro Techniques; Mal | 2011 |
Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arteriosclerosis; Cholesterol, LDL; Chromans; Diabetes Mell | 2003 |
Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Topics: Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Body Weight; Catalase; Diabetes Mellitus, E | 2005 |
Disparate effects of antidiabetic drugs on arterial contraction.
Topics: Animals; Arteries; Blood Pressure; Glyburide; Humans; Hypoglycemic Agents; In Vitro Techniques; Insu | 1997 |